Search

Your search keyword '"Gay, Carl Michael"' showing total 14 results

Search Constraints

Start Over You searched for: Author "Gay, Carl Michael" Remove constraint Author: "Gay, Carl Michael"
14 results on '"Gay, Carl Michael"'

Search Results

1. Triple blockade of Ido-1, PD-L1 and MEK as a potential therapeutic strategy in NSCLC

3. Results of a phase 1b study of osimertinib plus sapanisertib or alisertib for osimertinib-resistant, EGFR-mutant non–small cell lung cancer (NSCLC).

4. SWOG S2012: Randomized phase II/III trial of first line platinum/etoposide (P/E) with or without atezolizumab (NSC#783608) in patients (pts) with poorly differentiated extrapulmonary small cell neuroendocrine carcinomas (NEC).

5. Clinical outcome and potential benefits of post-progression immunotherapy for patients with metastatic NSCLC with primary resistance to ipilumumab and nivolumab in the LONESTAR phase III study.

7. Additional file 1 of Triple blockade of Ido-1, PD-L1 and MEK as a potential therapeutic strategy in NSCLC

11. Longitudinal tracking of ALK -positive lung cancer from plasma using circulating-tumor RNA and circulating-tumor DNA in the BRIGHTSTAR clinical trial.

13. Analysis of tumor- and circulating-free DNA methylation to identify clinically relevant small cell lung cancer subtypes.

14. SWOG S1929: Phase II randomized study of maintenance atezolizumab (A) versus atezolizumab + talazoparib (AT) in patients with SLFN11 positive extensive stage small cell lung cancer (ES-SCLC).

Catalog

Books, media, physical & digital resources